BioSpace News Archive

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces the sale of Ligand’s Vernalis research operations and internal programs to HitGen Inc. (SHA: 688222) for $25 million in cash. Under the terms of the agreement, Ligand will retain economic rights on complet

The Ohio State University Wexner Medical Center has secured $800,000 in grants to develop with Battelle the NeuroLife interface technology for home use.

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders for Q3 2020. Thomas Sandgaard , CEO of Zynex said: “Similar to most compani

Reducing payment and reimbursement barriers is the most important factor in driving provider uptake of cell and gene therapies, the Alliance for Regenerative Medicine (ARM) and the National Association of Managed Care Physicians (NAMCP) Medical Directors Institute concluded in a joint study announced today.

Therapeutics Solution International, Inc., (OTC Markets: TSOI), announced today the appointment of Serena Robella as Director of Sales.

The New England Journal of Medicine (NEJM), one of the world’s most respected medical journals, has weighed in on a Presidential candidate for the first time in its 208-year history.

In lieu of an in-person update to the media, Dr. Theresa Tam, Canada’s Chief Public Health Officer, issued the following statement

Waters Corporation (NYSE:WAT) will webcast its Q3 2020 financial results conference call live on Tuesday, October 27th at 8:00 a.m. eastern time.

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today confirmed receipt of a letter from PrimeStone Capital LLP (PrimeStone) to its Board of Directors and issued the following statement:

Evotec SE announced that it resolved on a capital increase from its authorised capital without pre-emptive rights against cash.